New study reveals how cannabis suppresses immune functions
The team, led by Dr Prakash Nagarkatti from the University of South Carolina, focused their research on cannabinoids, a group of compounds found inside the cannabis plant, including THC (delta-9 tetahydrocannabinol) which is already used for medical purposes such as pain relief.
"Cannabis is one of the most widely used drugs of abuse worldwide and it is already believed to suppress immune functions making the user more susceptible to infections and some types of cancer," said Dr Nagarkatti. "We believe the key to this suppression is a unique type of immune cell, which has only recently been identified by immunologists, called myeloid-derived suppressor cells, MDSCs."
While most immune cells fight against infections and cancers to protect the host, MDSCs actively suppress the immune system. The presence of these cells is known to increase in cancer patients and it is believed that MDSCs may suppress the immune system against cancer therapy, actually promoting cancer growth.
Dr Nagarkatti's team demonstrated that cannabinoids can trigger a massive number of MDSCs through activation of cannabinoid receptors. This research reveals, for the first time, that marijuana cannabinoids may suppress the immune system by activating these unique cells.
"These results raise interesting questions on whether increased susceptibility to certain types of cancers or infections caused from smoking marijuana results from induction of MDSCs," said Nagarkatti. "MDSCs seem to be unique and important cells that may be triggered by inappropriate production of certain growth factors by cancer cells or other chemical agents such as cannabinoids, which lead to a suppression of the immune system's response."
In a related study, also published in the European journal of Immunology, Dr Christian Vosshenrich from the Institut Pasteur in Paris, reveals that when cancer cells grow they produce a molecule called interleukin-1 β (IL-1β), which also triggers MDSCs. This study identifies how MDSCs produced during cancer growth also weaken the ability of immune cells to kill cancer cells.
"Marijuana cannabinoids present us with a double edged sword," concluded Dr Nagarkatti. "On one hand, due to their immunosuppressive nature, they can cause increased susceptibility to cancer and infections. However, further research of these compounds could provide opportunities to treat a large number of clinical disorders where suppressing the immune response is actually beneficial."
More information: Hedge. V, Nargarkatti. M, Nargarkatti. P, “Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties” European Journal of Immunology, November 2010. DOI:10.1002/eji.201040667
- hide
Related Stories
Flu deaths could be reduced thanks to cancer research
Nov 17, 2008 |
(PhysOrg.com) -- Cells involved in the body’s immune response to cancer are also implicated in influenza infection and could be targeted in new flu vaccination strategies, scientists at Oxford University have ...
Researchers describe how chronic inflammation can lead to stomach cancer
A multi-center research team, led by Columbia University Medical Center, has uncovered a major contributor to the cause of stomach cancer – the second leading cause of cancer-related mortality in the world. The team described ...
Study: Tumors inhibit immune system
Seattle scientists have shown that tumors can manipulate the immune system to stop it from attacking cancer cells, said a study published in Nature Immunology.
Endogenous cannabinoids linked to fetal brain damage imposed by maternal cannabis use
A critical step in brain development is governed by endogenous cannabinoids, ‘the brain’s own marijuana’. Studies conducted at Swedish medical university Karolinska Institutet, with participation of scientists from Europe ...
Embryonic stem cells can kill cancer cells
University of Minnesota scientists, in groundbreaking research, say they have used human embryonic stem cells to kill cancer cells.
No comments:
Post a Comment